swayd.
EN DE
Personalized mRNA Cancer Vaccine Clears Phase 3: Melanoma Recurrence Cut by Half
Flipboard

Personalized mRNA Cancer Vaccine Clears Phase 3: Melanoma Recurrence Cut by Half

mRNA cancer vaccine Phase 3 win: Merck and Moderna announced August 19 that intismeran autogene cut melanoma recurrence risk by roughly half

View offer
Open in swayd

Related

Quiet Luxury, Loud SalesArchive Denim RevivalThe Low-maintenance, High-impact Hair Trend Based on VibesTech Tuesday: Coppel Teams with First InsightManolo Blahnik x Emilia Wickstead Launch Capsule Collection With Net-a-porterAnemos Opens First NYC Pop-up